182 related articles for article (PubMed ID: 15957515)
1. Severity of chronic pain and its relationship to quality of life in multiple sclerosis.
Kalia LV; O'Connor PW
Mult Scler; 2005 Jun; 11(3):322-7. PubMed ID: 15957515
[TBL] [Abstract][Full Text] [Related]
2. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Pilutti LA; Dlugonski D; Sandroff BM; Klaren R; Motl RW
Mult Scler; 2014 Apr; 20(5):594-601. PubMed ID: 24009162
[TBL] [Abstract][Full Text] [Related]
4. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population.
Lester K; Stepleman L; Hughes M
J Behav Med; 2007 Apr; 30(2):177-86. PubMed ID: 17318458
[TBL] [Abstract][Full Text] [Related]
5. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
Sayao AL; Bueno AM; Devonshire V; Tremlett H;
Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
7. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.
Kroencke DC; Lynch SG; Denney DR
Mult Scler; 2000 Apr; 6(2):131-6. PubMed ID: 10773860
[TBL] [Abstract][Full Text] [Related]
8. The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
Mikula P; Nagyova I; Krokavcova M; Vitkova M; Rosenberger J; Szilasiova J; Gdovinova Z; Groothoff JW; van Dijk JP
Psychol Health Med; 2015; 20(6):653-61. PubMed ID: 25879302
[TBL] [Abstract][Full Text] [Related]
9. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
Tan-Kristanto S; Kiropoulos LA
Psychol Health Med; 2015; 20(6):635-45. PubMed ID: 25588098
[TBL] [Abstract][Full Text] [Related]
10. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
Rasova K; Brandejsky P; Havrdova E; Zalisova M; Rexova P
Mult Scler; 2005 Apr; 11(2):213-21. PubMed ID: 15794397
[TBL] [Abstract][Full Text] [Related]
11. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.
Morales-Gonzáles JM; Benito-León J; Rivera-Navarro J; Mitchell AJ;
Mult Scler; 2004 Feb; 10(1):47-54. PubMed ID: 14760952
[TBL] [Abstract][Full Text] [Related]
12. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.
Zamboni P; Galeotti R; Menegatti E; Malagoni AM; Gianesini S; Bartolomei I; Mascoli F; Salvi F
J Vasc Surg; 2009 Dec; 50(6):1348-58.e1-3. PubMed ID: 19958985
[TBL] [Abstract][Full Text] [Related]
13. The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis.
Julian L; Merluzzi NM; Mohr DC
Mult Scler; 2007 Jan; 13(1):81-6. PubMed ID: 17294615
[TBL] [Abstract][Full Text] [Related]
14. Sleep and fatigue in multiple sclerosis.
Stanton BR; Barnes F; Silber E
Mult Scler; 2006 Aug; 12(4):481-6. PubMed ID: 16900762
[TBL] [Abstract][Full Text] [Related]
15. Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
Montalban X; Comi G; O'Connor P; Gold S; de Vera A; Eckert B; Kappos L
Mult Scler; 2011 Nov; 17(11):1341-50. PubMed ID: 21727148
[TBL] [Abstract][Full Text] [Related]
16. Social anxiety in a multiple sclerosis clinic population.
Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
[TBL] [Abstract][Full Text] [Related]
17. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
Wolkorte R; Heersema DJ; Zijdewind I
Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
[TBL] [Abstract][Full Text] [Related]
18. Cognitive-behavioral classifications of chronic pain in patients with multiple sclerosis.
Khan F; Pallant JF; Amatya B; Young K; Gibson S
Int J Rehabil Res; 2011 Sep; 34(3):235-42. PubMed ID: 21642854
[TBL] [Abstract][Full Text] [Related]
19. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.
Chwastiak L; Ehde DM; Gibbons LE; Sullivan M; Bowen JD; Kraft GH
Am J Psychiatry; 2002 Nov; 159(11):1862-8. PubMed ID: 12411220
[TBL] [Abstract][Full Text] [Related]
20. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Pavsic K; Pelicon K; Ledinek AH; Sega S
Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
